Using Plasma Viral Load to Guide Antiretroviral Therapy Initiation to Prevent HIV-1 Transmission

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Murnane, Pamela M ^a   Hughes, James P ^a   Celum, Connie ^a   Lingappa, Jairam ^a   Mugo, Nelly ^a,c,d   Farquhar, Carey ^a   Kiarie, James ^a,c,d   Wald, Anna ^a,e   Baeten, Jared M ^a   Campbell, Mary ^a   Corey, Lawrence ^a   Coombs, Robert W ^a   Magaret, Amalia ^a   Juliana McElrath, M ^a   Morrow, Rhoda ^a   Mullins, James I ^a   Coetzee, David ^f   Fife, Kenneth ^g,p   Were, Edwin ^g,p   Essex, Max ^h   Makhema, Joseph ^h   Katabira, Elly ⁱ   Ronald, Allan ⁱ   Allen, Susan ^j,l,n,s   Kayitenkore, Kayitesi ^j,s   Karita, Etienne ^j,s   Bukusi, Elizabeth ^k,q   Cohen, Craig ^k,q   Kanweka, William ^l,s   Vwalika, Bellington ^l,s   Kapiga, Saidi ^m,r   Manongi, Rachel ^m,r   John Stewart, Grace ^a,c   Inambao, Mubiana ^n,s   Delany Moretlwe, Sinead ^o   Rees, Helen ^o   de Bruyn, Guy ^o   Gray, Glenda ^o   McIntyre, James ^o   Rwamba Mugo, Nelly ^a,c   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d KENYATTA NATIONAL HOSPITAL   (Kenya)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g MOI UNIVERSITY   (Kenya)

^h BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

ⁱ MAKERERE UNIVERSITY   (Uganda)

^j Rwanda Zambia HIV Research Group   (Rwanda)

^k KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^l Rwanda Zambia HIV 1 Research Group   (Zambia)

^m KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

ⁿ Rwanda Zambia HIV Research Group   (Zambia)

^o UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^p INDIANA UNIVERSITY   (United States)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r HARVARD UNIVERSITY   (United States)

^s EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; PLACEBO;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONDOM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SEXUAL BEHAVIOR; TREATMENT RESPONSE; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 84870779676     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051192     Document Type: Article

References (16)

1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med.
2. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, et al. (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092-2098.
3. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG, (2009) Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373: 48-57.
4. Dodd PJ, Garnett GP, Hallett TB, (2010) Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS 24: 729-735.
5. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. (2012) Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA 308: 387-402.
6. European AIDS Clinical Society (2011) Guidelines. Version 6- October 2011.
7. World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach: 2010 revision.
8. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, et al. (2001) Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357: 1149-1153.
9. Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, et al. (2012) Determinants of per-coital-act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 205: 358-365.
10. Novitsky V, Wang R, Bussmann H, Lockman S, Baum M, et al. (2010) HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission. PLoS One 5: e10148.
11. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, et al. (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362: 427-439.
12. Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, et al. (2010) Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One 5: e12598.
13. Anglemyer A, Rutherford GW, Baggaley RC, Egger M, Siegfried N (2011) Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev: CD009153.
14. Wang S, Xu F, Demirci U, (2010) Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol Adv 28: 770-781.
15. Okui L, Novitsky V, Bussmann H, Lockman S, Logan A, et al. (2012) Community distribution of HIV-1 RNA load and CD4+ cell counts: Botswana. 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA.
16. Brown MS, (2000) Coitus, the proximate determinant of conception: inter-country variance in sub-Saharan Africa. J Biosoc Sci 32: 145-159.